NEW YORK (GenomeWeb News) – Shares of Myriad Genetics were trading up 2 percent at $45.44 in mid-afternoon trade on the Nasdaq following the two-for-one split of its shares before the market opened today.
The Salt Lake City-based molecular diagnostics firm announced the split last month. Following the split, it has around 95 million shares outstanding.